Deferiprone in Alzheimer Disease

Дата публикации: 01-01-2025 00:00:00

This randomized clinical trial investigates whether the brain-permeable iron chelator deferiprone slows cognitive decline in people with Alzheimer disease.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Exploratory Tau Biomarker Results From a Study of BIIB080 in Alzheimer Disease	0	10.76	01-12-2023
2	Teriflunomide and Time to Clinical Multiple Sclerosis in Radiologically Isolated Syndrome	0	6.92	01-10-2023
3	White Matter Hyperintensities in Alzheimer Disease	0	6.14	01-12-2023
4	Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care	0	5.63	15-10-2024
5	Fecal Microbiota Transplantation for Treatment of Parkinson Disease	0	4.44	01-09-2024
6	Tau Oligomer–Containing Synapses Engulfed by Microglia and Astrocytes in Alzheimer Disease	0	7.6	01-11-2023
7	Copper drug clears toxic Alzheimer’s proteins and restores memory	0	9.29	15-06-2026
8	Scientists found a new Alzheimer’s trigger and a drug that stops it	0	8.74	08-06-2026
9	Dexmedetomidine alleviates sepsis-associated cognitive impairment via restoration of NREM sleep linked to prefrontal synaptic plasticity	7	8	14-07-2026
10	Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke	0	5.05	01-05-2024

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10.42. Источник: archderm.jamanetwork.com.